StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
FERVENTSYN.BO$16.34-0.67%
Fair $16.34+0.0%

FERVENTSYN.BO

Fervent Synergies Limited

Consumer Defensive / Food DistributionBSE

$16.34

-0.11 (-0.67%)

Fairly Valued+0.0%Fair Value $16.34Fund rank 25/100 · Data gapFallback financials|
SA 41/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-44.5M · quality 47.0/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 8/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

41/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · FERVENTSYN.BOLocal privado en este navegador · Fervent Synergies Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$817M

P/E

21.5x

↑

EV/EBITDA

21.1x

↑

ROE

6.7%

↓

Gross Margin

29.9%

↑

Debt/Equity

0.01

↓
52-Week Range$16
$15$30

TradingView lightweight chart

FERVENTSYN.BO price, volumen y niveles de valoración

Último $16.34Periodo -41.7%
Fair value: $16.34

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+52.3%

FCF CAGR

—

FCF margin

-27.2%

FCF / Net income

-1.17x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $163.5M · net income $38.2M · FCF $-44.5M

2023-FY → 2026-FY

Gross margin

29.9%+4.9% pts

Operating margin

23.4%+14.0% pts

Net margin

23.4%+18.4% pts

FCF margin

-27.2%-25.6% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$163.5M$163.5M$324.6M$243.1M$46.3M
Net Income$38.2M$38.2M$29.5M$-128.4M$2.3M
EBITDA$38.9M$38.9M$29.9M$-127.6M$4.8M
EPS——0.68-4.480.08
Gross Margin29.9%29.9%12.1%9.2%25.0%
Operating Margin23.4%23.4%9.1%6.2%9.5%
Net Margin23.4%23.4%9.1%-52.8%5.0%
Balance Sheet
Debt/Equity0.010.01———
Current Ratio221.56221.56———
Cash Flow
Free Cash Flow$-44.5M$-44.5M$-150.8M$-2.0M$-747000.00
Returns
ROE6.7%6.7%6.1%-42.3%0.5%
Valuation
P/E21.5021.5032.56—213.37
EV/EBITDA21.1121.1132.18—106.78
P/B1.431.431.982.021.18
Growth & Yield
Revenue Growth-49.6%-49.6%33.5%425.1%—
EPS Growth——115.2%-5700.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -18.0%

Total return

-18.0%

Start / end P/E

n/dx → n/dx

EPS bridge

0.68 → n/d

Residual

-18.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-18.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.